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Genetic sequences coding for type-C RNA viruses exist in a  naturally integrated 
form within the DNA of mouse cells (1).  In some inbred mouse strains, endogenous 
viruses  infectious for mouse  cells  are  spontaneously activated  and  replicate in  the 
animal. In such situations, there is an associated incidence of lymphoreticular neopla- 
sia that is correlated with the age on onset and level of virus expression (2, 3). Further, 
structural  proteins  of the  endogenous  type-C  viruses  have  been  found  in  a  high 
incidence in naturally occurring tumors of all histologic types in two strains of low 
leukemia incidence mice  (4).  This ubiquitous expression of viral proteins in tumor 
cells and the finding that at least two of the viral structural proteins, gp70 and p12, 
are immunologically reactive on the surface of virus infected cells (5)  has suggested 
the possibility that  the host's immune response to its endogenous virus might be of 
importance in determining its immunity to naturally occurring tumors. The host's 
naturally  occurring  cell-mediated  and  humoral  immunity  has  been  examined  by 
several groups of investigators. Natural cell-mediated cytotoxic reactivity of lymphoid 
cells against syngeneic and allogeneic tumor cells containing type-C viruses has been 
found  to  reside  in  specific  lymphocyte  subpopulations  (6-9).  In  addition,  many 
normal  mice  have  been  shown  to  possess  antibodies  directed  against  cell  surface 
antigens  associated with  type-C viruses  (10-12)  and  against  the viruses or purified 
viral proteins (13-16). 
In the present study, we demonstrate a virus-specific lymphocyte mediated immune 
response induced in response to endogenous type-C virus expression in aging mice. 
This response is mediated by a specific population of lymphocytes and coexists with 
humoral antiviral immune responses in the same host. In the process of attempting to 
define the interaction of these two immune responses, it was found that preincubation 
with  autologous  mouse sera  having antiviral  reactivity blocks the  lymphocyte me- 
diated cytotoxicity. Moreover, highly specific heterologous antisera  to type-C viral 
proteins contained high-titered blocking activity which could be removed by absorp- 
tion  with  purified  viral  proteins,  thus  establishing  the  virus  specific nature  of the 
target antigens for both the lymphocyte cytotoxicity and the blocking activity. 
Anima/s. 
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Materials and Methods 
Inbred normal male or female  BALB/cCr mice of various  ages were  used  for 
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natural immunity studies. The mice were  bred and aged at  the Microbiological Associates, 
Walkersville, Md., facility. Weanling BALB/c mice were used to prepare immune lymphocytes 
by injection i.m. of ~-105 focus-forming U/0.1 ml of a Moloney leukemia virus pseudotype of 
1  Moloney sarcoma virus (MSV [MuLV]).  Regressor mice were sacrificed 10-14 d after injection 
of the virus and their spleens removed for preparation of attacker cells. 
Antiserum.  Individual  or pooled normal mouse serum was collected from the sacrificed mice, 
aliquoted, and stored at -70°C. Antiserum to R-MuLV gp70,  p30,  p15, p12,  and pl0 were 
prepared according to published procedures (17, 18). Hyperimmune BALB/c anti-R-MuLV 
serum was obtained by immunizing  2-3-too-old BALB/c mice with 12 doses of Tween-80 (Atlas 
Chemical Industries, Inc., Wilmington, Del.)-ether disrupted R-MuLV. The first injection was 
administered subcutaneously using 200  /~g  virus mixed with  an equal  volume of Freund's 
Complete Adjuvant. The remaining immunizations, 50 #g virus each, were given by the i.p. 
route at 2-4-wk intervals. 
Target Cells.  The WM-7 cell line is a virus-free tumor cell line derived from a spontaneously 
occurring tumor of the BALB/c mouse (19). Subcultures of WM-7 were productively infected 
with either an endogenous BALB/c-derived ecotropic virus or with the Rauscher (R) strain of 
murine leukemia virus (MuLV) and are designated B-WM-7 and R-WM-7, respectively (19). 
Normal  rat  kidney (NRK)  cells  have  been described  (20). A  feline embryo fibroblast line 
designated FFc60WF was  obtained from Naval Biological Research  Laboratories, Oakland, 
Calif.  and  subcultures were  productively infected  with  FeLV.  Cell  lines were  constantly 
monitored (at  each cytotoxicity assay)  for the presence of virus by measuring poly (rA) oligo 
(dT)-directed reverse  transcriptase activity in culture fluids (21). The virus tropism and the 
percentage of infected cells was determined periodically by an infectious center assay (22, 23). 
Virus.  Sucrose density gradient-purified R-MuLV was obtained from the Frederick Cancer 
Research Center, Frederick, Md.  through the courtesy of R. V. Gilden. The JLS-V9-grown 
virus was  partially purified with two cycles of zonal centrifugation and concentrated either 
1,000-fold  (vaccine for anti-R-MuLV preparation) or 5,000-fold  (for serum absorption). The 
whole (1,000-fold concentrated) and lysed virus had complement fixation titers of 1:160 and 1: 
640,  respectively, against anti-R-MuLV-p30 and total  protein concentration of 2.1  mg/ml. 
Formalin-inactivated,  Tween-80-ether-disrupted R-MuLV vaccine was prepared as previously 
described (24). 
Virus Infectivity  Assay.  Lymphocyte suspensions from spleens were  inoculated at  5  ×  106 
cells/plate on 24-h cultures containing DEAE-dextran-treated SC-1 wild mouse embryo cells. 
Plaques were  scored  with the XC-assay procedure  (21) at  the  7th d  using duplicate plates. 
Passage on Day 7 and 14 was performed by scraping cells from one tissue culture plate into 0.6- 
ml supernatant culture fluid. Fresh duplicate 24 h  cultures of SC-1  cells were subsequently 
inoculated with 0.2 ml of the resulting cell suspension and tested 7 d later by the XC-assay. 
Preparation and  Pretreatment of Lymphocytes.  Spleen and thymus were  minced under sterile 
conditions in RPMI-1640 (National Institutes of Health Media Unit, Bethesda, Md.), passed 
through cotton gauze, washed twice with RPMI-1640, and resuspended in RPMI-1640 con- 
taining 20% fetal bovine serum (FBS) and glutamine. To determine the effect of antiserum and 
complement on the effector cells, 5-10 ×  107 spleen lymphocytes were incubated with 1:2 final 
dilution ofAKR anti-theta C3H ascetic serum (Bionetics Laboratory Products, Litton, Bionetics 
Inc., Kensington, Md.)  in RPMI-1640 with  10% FBS  for  30 min at room temperature. The 
cells were washed once and the cell pellet was resuspended in a  1:3 dilution of nontoxic rabbit 
serum  as  the  complement source  (Grand Island Biological  Co.,  Grand Island, N.  Y.)  and 
incubated for 45 min at 37°C. The cells were washed twice, counted, and adjusted to 107 cells/ 
ml concentration for cytotoxicity assay at a ratio of surviving attacker: target cell of 200:1. The 
phagocytic cells were removed with carbonyl iron according to the method published (25, 26). 
For the removal of the nylon-adherent cells, the spleen cells were passaged over a nylon column 
prepared with teased, washed fibers from Fenwal Leukopaks (Fenwal Inc., Walter Kidde & Co. 
Inc., Ashland, Mass.).  The columns were first washed with Hank's balanced salt solution and 
then with RPMI-1640 medium with 10% FBS. The cells at a concentration of 107/ml suspended 
in RPMI-1640 with  10% FBS were  added to the column. After incubation, the column was 
washed with  10 ml medium, the effluent cells were  collected and used as attacker cells. For 
I Abbreviations used in this paper: FBS, fetal bovine serum; MSV, Moloney sarcoma virus; MuLV, murine 
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removal of cells with receptors for complement or immunoglobulins, spleen cell suspensions 
were incubated on monolayers containing sheep erythrocytes and anti-E antibodies--Cordis 
Laboratories, Miami, Fla., plus complement according to the published methods (27, 28). The 
nonadherent cells were collected from the supernates. The cell concentration was adjusted to 
107 cells/ml and used for the cytotoxicity assay. 
Cellular Cytotoxicity Assay•  The microcytotoxicity version of the  published procedure was 
employed (29). Target cells  (1.0  ×  107 cells/ml) were  labeled with 200 pCi of 51Cr (200-500 
mCi/mg sodium chromate specific  activity, New England Nuclear, Boston, Mass.).  5  ×  103 
labeled cells/0.1 ml volume suspended in RPMI- 1640 with 10% FBS and 1 ×  106/0.1 ml spleen 
or  thymus lymphocytes were  delivered into Falcon Micro-Test II wells  (BioQuest, BBL,  & 
Falcon Products, Bectin, Dickinson, & Co., Cockeysville,  Md.). The test was incubated for  18 
h. The microplate was then centrifuged at 1,500 rpm for 10 min, and 0.1 ml from each well was 
sampled into 10 ml of Aquasol-2 (New England Nuclear) and counted for 10 min in a Beckman 
LS-350 beta counter (Beckman Instruments, Inc., Fullerton, Calif.).  Each sample in the assay 
was performed in quadruplicate and the % specific lysis computed as follows: 
cpm of supernate -  cpm counter background 
% isotope release  =  total cpm incorporated into cells -  cpm counter background ×  100. 
% specific lysis 
% isotope release of spleen lymphocytes -  % isotope release of thymus lymphocytes. 
The % specific lysis was considered to be positive when a comparison of the means of the spleen 
lymphocyte samples with the control thymus lymphocyte samples gave a P value of 0.01 or less 
by the Dunnett test. 
Blocking of Cell-Mediated Cytotoxicity.  Serum dilutions in RPMI-1640 in 0.1 ml volumes were 
added to the target cells and incubated for 60 min at 37°C in the presence of 5% CO2. After 
incubation, 10n/0.1 ml lymphocytes were added and the test  was incubated for  18 h. The % 
specific lysis was calculated as described above. Blocking was evaluated by a comparison of the 
% specific lysis obtained with spleen lymphocytes with the % specific lysis obtained with spleen 
lymphocytes in the presence of serum. The blocking was considered to be significant when a 
comparison of the means gave a P  value of 0.01 or less calculated by the Dunnett test.  The 
blocking titer of a serum was defined as the highest dilution of the serum which gave significant 
blocking as defined above• 
Humoral Cytotoxicity Assay.  The  assay  used  was  a  modification of previously published 
procedures (5, 30). The assay was carried out in Micro-Test II plates using 5  ×  10a/0.1 51Cr- 
labeled target cells, 0.1-ml serum dilutions, and 0.1  ml of 1:4 dilution nontoxic rabbit serum 
(complement). At the end of the assay the plates were  centrifuged for  5 min at  1,500 rpm, 
placed on crushed ice, and 0.1  ml of each was transferred to counting vials containing 10 ml 
Aquasol-2 (New England Nuclear, Boston, Mass.).  The titer was given by the highest serum 
dilution in which the percentage specific lysis was significant at the 99% confidence level using 
the conservative Dunnett test. 
Immunoprecipitation of l25I-Labeled Type-C Virus Structural Proteins.  The isolation and 125I-label- 
ing of R-MuLV structural proteins, including  gag gene-coded components, p30, p15, p12, and 
p 10, and the envelope glyeoprotein, gpV0, has been previously reported (17). Immunopreeipi- 
•  125  tauon assays were performed by testing sera at serial twofold dilutions for ability to bind  I- 
labeled viral proteins (10,000 cpm). Reaction mixtures contained 0.01 M Tris-HCl, pH 7.8, 1.0 
mM EDTA, 0.4% Triton X-100, 1% bovine serum albumin, and 0.05 M NaCI in a total volume 
of 0.2 ml. In assays using 125I-labeled p 15 and gpV0 the concentration of NaC1 was increased to 
0.2 M. After incubation  for 3 h at 37°C and 18 h at 4°C, 0.025 ml pig anti-goat immunoglobulin 
G was added to each tube and incubation continued for a further 3 h at 37°C and 1 h at 4 °. 
Samples were subsequently diluted to  1 ml with cold 0.01 M Tris-HCl, pH  7.8, 0.1  M  NaCI 
buffer containing 0• 1% Triton X-100, antigen-antibody  complexes precipitated by centrifuga- 
tion at 2,500 rpm for  15 rain, supernates aspirated, and radioactivity in supernates measured 
in a Searle model 1285 gamma counter (Searle  Diagnostics, Des Plaines, Ill.). 
Results 
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TABLE  I 
Age-Related Natural Cytotoxidty of BALB/c Spleen Lymphocytes against Target Cells Shedding Ecotropic 
Class I or Rauscher-MuL V* 
Source of lyre-  Percent specific lysis  against 
phocytes (age of  Pool 
No.  FeLV  mice)  B-WM-7  R-WM-7  WM-7  R-NRK  NRK  FF 60WF  FF 60WF 
mo  c  ( 
1  1  <2.0  <2.0  <2.0  4.5  4.2  4.6  5.4 
1  2  <2.0  <2.0  <2.0  2.5  2.9  3.6  3.8 
6  1  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0 
6  2  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0 
12  1  3.3  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0 
12  2  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0  <2.0 
18  1  19.3  t  15.1 t  <2.0  13.4t  <2.0  4.2  <2.0 
18  2  23.9t  16.1~  <2.0  12.8~  <2.0  3.1  <2.0 
* Spleen and thymus pools from five mice each were prepared and suspended in RPMI-1640,  1.0  ×  107 
cells/ml. 1.0 ×  106 attacker lymphocytes and 5.0 ×  103 labeled target ceils were incubated in Micro Test 
II wells for 18 h at 37°C. The microplate was then centrifuged at 1,500 rpm for 10 min and 0.1 ml from 
each well was sampled  into  10 ml of Aquasol-2 and counted  for  10 min  in a Beckman LS-350 beta 
counter. All samples were tested in quadruplicate. 
~: The percent-specific lysis  was calculated as presented in Materials and Methods and was considered to 
be significant when a comparison of the means of the spleen lymphocyte samples with the control thymus 
lymphocyte samples gave a P value of--~0.01. 
Virus.  Spleen lymphocytes were obtained from normal BALB/c mice ranging from 
1  to  18  mo  old.  Lymphocyte pools were  prepared  from  five  mice  and  tested  in  a 
chromium  release  cytotoxicity assay  against  a  variety  of syngeneic  and  allogeneic 
target  cells that  were  virus-free or  infected  with  murine  and  feline type-C  viruses. 
Lymphocyte  pools  from  18-mo-old  mice  showed  a  striking  virus  specific  activity 
against syngeneic target cells (WM-7) productively infected with either an endogenous 
ecotropic BALB/c  virus  (B-WM-7)  or R-MuLV  (R-WM-7)  (Table  1).  Noninfected 
syngeneic target cells showed no activity against lymphocytes from this age group or 
any of the age groups  tested.  Lymphocytes obtained from  1 mo and  6-too-old mice 
showed no activity against B-WM-7 or R-WM-7 whereas those from  12-mo-old mice 
exhibited low level activity. Allogeneic rat cells, noninfected  (NRK)  and  R-MuLV 
infected (R-NRK) also gave age-related, virus-specific reactivities when tested against 
lymphocyte pools from  18-mo-old mice  (Table  1).  Of interest was an  apparent  low 
level allogeneic reactivity exhibited  by  lymphocytes from  only  1-mo-old mice  that 
was not related to the virus. Allogeneic cat cells, noninfected FFc60WF, and FeLV- 
infected  (FeLV-FFc60WF),  were  also  tested  against  attacker  lymphocytes  from 
BALB/c mice of various ages. Only lymphocytes from  18-mo-old mice gave low level, 
but  significant  reactivity against  FeLV  infected  but  not  the  noninfected  cell lines, 
and  again  only  lymphocytes  from  1-mo-old  mice  gave  a  nonspecific  allogeneic 
reactivity. 
Attempts  to  Ablate  the  Virus-Specific  Lymphocyte-Mediated  Cytotoxicity.  Lymphocyte 
pools  were  prepared  from  spleens  of  18-too-old  mice  and  exposed  to  a  variety  of 
treatments  in  an  attempt  to  identify  the  specific lymphocyte  population  that  was 
mediating the cytotoxic reactivity. Treatment  of the spleen lymphocyte suspensions 
with  anti-0 serum  and  complement  had  no  effect  on  the  cytotoxic activity of the 
lymphocytes directed against the B-WM-7 target cells (Table II). The activity of the 362  LYMPHOCYTE-MEDIATED  IMMUNITY TO  TYPE-C  VIRUS  IN THE  MOUSE 
TABLE II 
Effect of Anti-T-Cell  Serum or Removal of Lymphocyte Subpopulations on the Cytotoxic Activity of 
Lymphocytes Obtained  from Normal 18-Mo-Old BALB/c Mice* 
Source of Lymphocytes 
Treatment 
18-mo-old BALB/c~ 
Pool 1  Pool 2 
Immune positive control§ 
Pool 1 
B-WM-7  WM-7  B-WM-7  WM-7  B-WM-7  WM-7 
percent.specific l~sis against 
None  1  1.4[]  <2.0  10.1[]  <2.0  14.6][  <2.0 
Anti-T and comple-  8.91[  <2.0  8.11[  <2.0  2.1¶  <2.0 
ment 
Complement  10.51[  <2.0  10.41[  <2.0  12.8tl  <2.0 
Nylon column  14.811  <2.0  13.711  <2.0  13.71[  <2.0 
EA  11.711  <2.0  8.411  <2.0  11.811  <2.0 
EA complement  13.111  <2.0  9. l II  <2.0  11.01l  <2.0 
Carbonyl iron  12.111  <2.0  10.211  <2.0  10.411  <2.0 
* The cell-mediated cytotoxicity assays were performed as described in Table I. 
A spleen lymphocyte pool from 25 BALB/c  mice of 18-too-old was prepared and was divided for the 
respective treatments which are described in Materials and Methods. 
§ Weanling BALB/c mice were given an i.m. inoculation of 105 focus-forming units of MSV virus. Spleens 
were removed from the regressors 10-14 d after injection. 
H  As in Table I. 
¶ The percent-specific lysis  was considered to be significant when a comparison of the means of the immune 
spleen lymphocyte samples with the control normal spleen lymphocyte samples gave a P value of ~0.01. 
anti-0 serum was confirmed by treatment of immune lymphocytes from BALB/c mice 
in which an MSV (MuLV)-induced tumor had regressed. The anti-0 sera significantly 
reduced  the  cytotoxic activity of these  immune  lymphocytes as compared  to  non- 
treated  immune  lymphocytes tested  against  B-WM-7  (Table  II). Treatment  of the 
normal  or immune  lymphocytes with  complement  alone or with  carbonyl  iron did 
not  significantly  affect  the  cytotoxic  activity  nor  did  passage  of  the  lymphocyte 
suspensions through a  nylon column.  For removal of cells with receptors for comple- 
ment or immunoglobulins, the spleen cell suspensions were also incubated on mono- 
layers containing sheep erythrocytes and  EA with  and without  complement.  These 
treatments  did not  significantly affect  the cytotoxic reactivity of lymphocytes from 
18-mo-old mice nor of immune lymphocytes from MSV regressor mice against the B- 
WM-7 target cells. 
Relationship of Natural  Virus-Specific,  Cell-Mediated and Humoral Immunity to Endogenous 
Virus Expression  in the Host.  Individual BALB/c mice ranging in age from  1 to  18 mo 
were  examined  for expression of endogenous  ecotropic virus and  its relationship to 
their virus-specific, cell-mediated, and humoral immune status. Endogenous ecotropic 
virus was quantitated by cocultivation of 5  ×  10  6 live spleen lymphocytes with SC-1 
cells  and  scoring  for  plaques  both  at  7  d  and  subsequent  to  subculturing  and 
incubation for an  additional  7 or  14 d.  By this sensitive assay the endogenous virus 
incidence (and  titer--data not shown)  was  found to increase progressively with  age 
with  the  1-mo-old mice  yielding no  isolates of 5  tested  and  the  18-mo-old mice,  4 
isolates of 5  tested  (Table  III). The  lymphocyte mediated cytotoxicity to  B-WM-7 
increased progressively with age as did the humoral immune response to viral antigen KENDE  ET  AL. 
TABLE  III 
Age-Related Natural CMI and Humoral Immunity to Ecotropic Virus by Cytotoxicity and 
Radioimmunoassays: Relationship to Endogenous Virus Expression* 
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Age of 
mice 
Animal No.  Ecotropic:~  Precipitating~ 
virus  antibody 
Lymphocyte-  Antibody-mediated cytotoxic- 
mediated cyto-  ity¶ 
toxicityll 
Percent-specific  lysis against 
gp70  B-WM-7  B-WM-7  WM-7 
mo 
1 
6 
12 
18 
1-5  -  <10  <2.0  <2.0  NT 
1-4  -  <10  <2.0  <2.0  NT 
5  +  20  <2.0  <2.0  NT 
1  +  20  5.4**  <2.0  NT 
2  -  <10  <2.0  <2.0  NT 
3  +  <10  <.20  <2.0  NT 
4  +  20  7.1"*  3.1  NT 
5  -  <10  <2.0  <2.0  NT 
1  +  40  15.6"*  5. It  <2.0 
2  +  80  19.4"*  4.3  <2.0 
3  +  160  7.3**  6. It  <2.0 
4  -  40  4.2  2.0  <2.0 
5  +  80  10.1 **  2.0  <2.0 
* Individual serum was  assayed  for  precipitating and  cytotoxic antibodies and  the autologous spleen 
lymphocytes for cellular cytotoxicity and for ecotropic virus expression. 
~: 5  ×  10  s spleen  lymphocyte suspensions  were inoculated onto 5  ×  106 SC-1 wild mouse embryo cells. 
The plaques were scored  by the XC-assay  at day 7. Subcultures of SC-1 cells were also passaged  at  7 
and  14 d and assayed  7 d later by the XC assay. 
§ Sera were assayed  at  serial  twofold dilutions  for  ability to  bind  lzSI-labeled purified  gp70  antigen. 
Results are expressed  as the reciprocal  of the highest  dilution at which  10% of the 12SI-labeled antigen 
was precipitated. 
I] Cellular cytotoxicity assays were performed as described  in Table 1. 
¶ Humoral cytotoxicity was carried out in Micro-Test II wells using quadruplicate samples of 5 x  103/0.1 
ml SlCr-labeled  target cells, 0.1-ml serial dilutions of BALB/c serum and 0.1 ml of nontoxic dilutions of 
rabbit serum (complement). The percent-specific  lysis and its significance  was calculated as previously 
described  (5). 
** As in Table I. 
as  measured  by  precipitating  activity  to  the  major  viral  glycoprotein  gp70  and  by 
humoral  eytotoxic activity to B-WM-7  cells. A  high  degree of correlation  was  found 
between  the  presence  of infectious  virus  and  the  virus-specific immune  responses  in 
the  individual  mice.  The  data  suggested  further  that  the  immune  activity  was  in 
response to endogenous  virus expression as the immune  activity was measurable  only 
in  mice  which  yielded  infectious  virus.  Viral-specific,  cell-mediated,  and  humoral 
immune  activity occurred  in the same mice but  no definite quantitative  relationship 
of one activity with the other was observed. 
Inhibition  of the Cytotoxic Activity of Spleen Lymphocytes with Autologous Sera.  To deter- 
mine  whether  autologous  mouse  sera  would  inhibit  the  lymphocyte  mediated  cyto- 
toxicity, target cells, including B-WM-7, R-WM-7,  and WM-7  are preincubated  with 
various dilutions of sera for 1 h  before measurement  of lymphocyte-mediated  activity. 
The cytotoxie activity of lymphocytes from  18-mo-old mice was significantly reduced 
by  preincubation  of either  B-WM-7  or  R-WM-7  with  serum  pools  from  18-mo-old 364  LYMPHOCYTE-MEDIATED IMMUNITY TO TYPE-C VIRUS IN THE MOUSE 
TABLE IV 
Blocking of the Cytotoxic Activity of Spleen Lymphocytes  from 18-Mo-Old BALB/c Mice with Autologous 
or Virus-lmmune Sera 
Sera* 
Lymphocytes from  18-too-old BALB/c  Lymphocytes from  l-mo-old BALB/c 
Percent-specific  lysis against 
R-WM-7  B-WM-7  WM-7  R-WM-7  B-WM-7  WM-7 
None  17.4  19.6  3 4  <2.0  <2 0  <2 0 
l-too-old B/c  16.4  17.0  <2.0  <2.0  <2 0  <20 
I8-mo-old B/c  9.2~c  8.4:~  <2.0  <2.0  <2.0  <20 
18-too-old  B/c  (absorbed  with  R-  1@2  172  <20  <2.0  <2.0  <2.0 
MuLV) 
18-too-old  B/c  (absorbed  with  R-  15.8  17.9  <2.0  <2.0  <2.0  <2.0 
gp70) 
B/c anti-R-MuLV  6.4~:  9.1 ~c  <2.0  <2.0  <2.0  <2.0 
B/c  anti-R-MuLV  (absorbed  with  15.1  15.3  <2.0  <2.0  <2.0  <2.0 
R-MuLV) 
B/c  anti-R-MuLV  (absorbed  with  7.1~c  95~  <2.0  <2.0  <2.0  <2.0 
WM-7 cells) 
* Normal or immune sera were mixed with equal volumes of 10 mM Tris HCI (pH 7.8), containing  1.0 mg of disrupted R-MuLV or 50 ~g of 
R-MuLV gp70 and incubated  for  1 h at 37°C and  18 h overnight at 4°C, followed by centrifugation at  100,000 g for 2 h. Immune sera were 
also mixed with an equal volume of cell pack, incubated for  1 h at 37°C and  18 h overnight at 4°C, followed by eentrifugation at  1,500 rpm 
for  10 min. BALB/e anti-R-MuLV immune sera was produced as previously published (43). 
~:The blocking of cellular cytotoxicity  was performed  by adding quadruplicates  of 0.1  ml serial serum  dilutions into  5.0  ×  103 target cells. 
After  l-h incubation,  1.0  ×  10n/0. l  ml lymphocytes were added into the microplate wells containing the target cells and the serum and the 
test was incubated  for  18 h. Blocking was evaluated by a  comparison of the percent-specific lysis obtained with spleen lymphocytes with the 
percent-specific lysis obtained with spleen lymphocytes in the presence of serum dilutions. The blocking was considered to be significaqt when 
a  comparison of the means gave a  P value of--<0.01. 
mice. This blocking activity of the  serum was completely absorbed with  intact  R- 
MuLV or with highly purified R-MuLV-gp70 (Table IV). Sera from 1-mo-old mice 
had no blocking activity against the cytotoxic lymphocytes obtained from 18-mo-old 
mice. Lymphocytes from  1-mo-old mice were not cytotoxic to B-WM-7 or R-WM-7 
and preincubation of the target cells with sera from young or old mice did not affect 
this  reactivity.  Immune  sera  obtained  from  BALB/c  mice  hyperimmunized  with 
inactivated R-MuLV significantly blocked the lymphocyte-mediated cytotoxic reac- 
tivity. Moreover, absorption of this immune sera with R-MuLV removed this blocking 
activity whereas absorption with WM-7 cells did not  (Table IV). 
Analysis of Blocking  Activity of Individual  Autologous Mouse  Sera," Correlation of Blocking 
Activity  with Humoral Cytotoxic Activity.  Individual mouse sera were tested for ability 
to  block  their  autologous  lymphocyte's reactivity  to  B-WM-7.  Examination  of  10 
individual mice yielded 7 whose sera gave statistically significant (P <  0.01)  blocking 
when tested at a  dilution of 1:10  or greater (Table V). Of these latter sera, six were 
found to be reactive in a humoral cytotoxicity assay, whereas the three sera having no 
blocking  activity  were  all  unreactive  in  the  cytotoxicity  assay.  Further,  the  sera 
yielding  the  highest  blocking  titers  also  were  generally  noted  to  yield  the  highest 
cytotoxicity titers,  although  titers  obtained  in  the  latter  assay were never found  to 
exceed  1:40. 
Blocking  of the  Cytotoxic Activity  of Spleen  Lymphocytes  with  Antisera  Specific for  the 
Polypeptides of R-MuLV.  High-titered monospecific antisera directed against individ- 
ual  R-MuLV  structural  proteins  were  tested  for  blocking  activity  to  determine 
whether  virus  specific  reactivities  by the  spleen  lymphocytes could  be  blocked  by 
antisera  specific  for  the  viral  proteins  and  if so,  to  determine  which  polypeptide KENDE  ET  AL.  365 
TABLE V 
Analysis of the Blocking Activity of Individual Autologous Mouse Sera: Correlation of Blocking Activity 
with Humoral Cytotoxic Activity 
Lymphocytes with 
Lymphocytes  autologous sera 
Mice  P value of block-  Cytotoxiclty ti-  Blocking titer§ 
No.  percent-specific lysis*  ing  ter:]: of autolo-  of autologous 
gous sera  sera (P "¢ 0.01) 
B-WM-7  B-WM-7 
1  17.3  7.7  0.005 (S)  20  160 
2  12.7  10.6  0.294 (NS)  <10  <10 
3  14.8  4.6  0.006 (S)  20  40 
4  13.7  8.6  0.014 (S)  10  10 
5  11.2  10.9  0.831 (NS)  <10  <10 
6  21.4  5.4  <0.001 (S)  40  640 
7  18.1  7.1  0.003 (S)  10  40 
8  14.3  4.1  0.005 (S)  20  160 
9  15.1  6.2  0.007 (S)  <10  10 
10  10.9  10.7  0.922 (NS)  <10  <10 
* Spleen lymphocytes from individual animals were assayed for cell-mediated cytotoxicity as described in 
Table I and for blocking of the cytotoxicity with the autologous serum as described in Table IV. The 
blocking was considered to be significant when a comparison of the means gave a P value of ~0.01. 
:~ The humoral cytotoxicity assay was performed as described in Table III using the respective autologous 
serum. The titer was given by the highest dilution of the serum in which the percent-specific lysis was 
significant at P ~  0.01. 
§ The blocking titer is expressed as the highest serum dilution at which the percent-specific lysis obtained 
with spleen lymphocytes was significantly different  (P _< 0.01) from the percent-specific lysis obtained 
with spleen lymphocytes in the presence of the test serum. 
specific antisera were active in the blocking assay. Table VI shows the reactivities of 
each  polypeptide specific antisera  with  highly purified preparations  of each  of the 
major structural proteins of R-MuLV  as determined by radioimmunoassay. It is seen 
that  high-titered blocking activity was observed in anti-R-gp70 sera and  in anti-R- 
p12  sera  (Table VI).  Whereas anti-R-pl5 and  anti-R-p30 sera also gave significant 
but low level activities, the possibility that this was due to the presence of low levels 
of contaminating anti-pl2 reactivity could not  be excluded. Anti-R-pl0 was highly 
monospecific and was nonreactive in the blocking assays. It should be noted, however, 
that  the blocking activity of even  the most  active sera was not complete even when 
tested  at  low  dilutions  (1:10).  For  example,  at  antisera  dilutions  of  1:10,  percent 
specific lysis values  of 6.1  and  6.8  were  obtained  for anti-R-gp70  and  anti-R-pl2, 
respectively, as compared to  18.9 for normal goat sera (Table VI). 
Removal  of blocking and precipitating  activity  of anti-R-gp70 and anti-R-p l2 by absorption 
with purified gp70 and p12.  To further establish the specificity of blocking activity of 
sera directed against R-MuLV  structural proteins, absorptions of such antisera with 
purified viral proteins was carried out. The results (Table VII) show that the blocking 
activities of anti-R-MuLV-gp70 and anti-R-MuLV-p 12 were reduced by at least two 
logs by absorption with their respective homologous proteins. In contrast, absorption 
with heterologous proteins (i.e., absorption of anti-R-MuLV-gp70 sera with p 12 and 
anti-R-MuLV-p 12 with gp70) had no significant effect on the blocking activities. The 
reduction  of the  precipitating  activities  of the  antisera  by  absorption  was  highly 
correlated with the reduction of their respective blocking activities. 366  LYMPHOCYTE-MEDIATED  IMMUNITY  TO  TYPE-C  VIRUS  IN  THE  MOUSE 
TABLE  VI 
Blocking of Spleen Lymphocyte Cytotoxic Activity by Antisera Directed against Individual R-MuL V 
Structural Proteins* 
Antibody titer as measured by 
Sera  Immunoprecipitation of 12SI-labeled 
gp70  pl5  p12  p30  pl0 
percent-spe- 
Blocking  cific lysis (1: 
reactivity  10) 
Control  <10  <10  <10  <10  <10  <10  18.9 
Anti-R-MuLV: 
gp70  80,000  <10  <10  160  <10  >5,120  6.15[: 
pl5  <10  5,120  160  1,280  <10  320  9.45 
p12  <10  <10  1,280  <10  <10  5,120  6.85 
p30  20  <10  160  750,000  80  80  10.35 
pl0  <10  <10  <10  80  3,500  <10  18.1 
* Immunoprecipitation of ~251-1abeled viral proteins was performed as described in Methods. Results are 
expressed as the highest serum dilution at which 10% precipitation of the appropriate ~25I-labeled antigen 
was achieved (1,000  cpm as compared to a background level of 50-150 cpm) and represent mean values 
of triplicate determinations. Blocking assays were performed as described in  Materials and  Methods. 
Results are expressed as the highest serum dilution at which the percent-specific lysis obtained the spleen 
lymphocytes was significantly different (P _< 0.01)  from the percent-specific lysis obtained with spleen 
lymphocytes in the presence of the test serum. 
5 As in Table III. See footnote ** 
TABLE  VII 
Removal of Blocking Activity in Anti-R-MuL V gp 70 and p l 2 Sera by Absorption 
with the Homologous Protein 
Antibody titer as measured by:5 
Absorbed  Immunoprecipitation of 125I- 
Sera  with*  labeled 
p12  gp70 
Blocking reac- 
tivity 
control  --  < 10  < 10  <20 
anti-R-MuLV gp70  --  <10  80,000  >5,120 
gp70  <10  512  80 
p12  <10  60,000  >5,120 
anti-R-MuLV p12  --  1,280  <10  5,120 
gp70  1,280  <10  5,120 
p12  <10  <10  <20 
* Absorptions were  performed by  incubation  of 0.005  ml  sera with  100 pg of the 
appropriate purified protein in 0.05 ml 0.01  M Tris-HCl, pH  7.8,  1.0 mM EDTA, 
0.4%  Triton X-100, 0.05  M  NaCI  for 1 h  at  37°C and  18 h, overnight. Sera were 
subsequently clarified by centrifugation at  100,000 g for 2 h. 
$ Immunoprecipitation of 12SI-labeled viral proteins and titration of serum blocking 
activity was performed as described in the legend to Table VI. 
Discussion 
The results of the present study establish the presence of natural cytotoxic reactivity 
of spleen lymphocytes from BALB/c mice against syngeneic or allogeneic target cells 
infected with an endogenous ecotropic type-C virus (B/c-MuLV) or with R-MuLV. 
The virus-specific nature of the spleen cell cytotoxicity was demonstrated by the lack 
of reactivity with virus-free syngeneic or allogeneic cells.  Low level but significant 
reactivity of the lymphocytes against  a  feline cell infected with FeLV may reflect KENDE ET AL.  367 
cross-reactive antigenic determinants shared by the major structural glycoproteins of 
MuLV  and  FeLV  (31).  Type-C  virus  infection of cells  has  been  shown  to  confer 
antigenic  and  immunogenic changes  to  the cell that  are  due  in  part  to structural 
proteins  of  the  virus  but  also  to  nonvirion  antigens  that  are  expressed  in  less 
immunogenic form in homologous noninfected cells  (19,  32).  In an attempt to rule 
out  the possibility that  the natural  killer cell activity observed was due to reaction 
with nonvirion antigens in the infected target cells, competition assays with concen- 
trated virus were performed. The concentrated virus clearly competed with the target 
cells  for  the  lymphocyte reactivity  confirming  the  latter's  virus-specific  reactivity 
(unpublished observations). 
The naturally occurring cytotoxic activity of spleen lymphocytes was not evident in 
mice lacking isolatable ecotropic virus, and  with  aging,  the incidence of isolatable 
virus was found to rise progressively, as did the natural cellular cytotoxic reactivity. 
The close correlation between these two activities suggested strongly that the natural 
cellular cytotoxicity represents a specific response to endogenous type-C virus expres- 
sion in the host. Natural cell-mediated cytotoxicity has been previously reported in 
several mouse strains,  including the BALB/c mouse (6-9). This cytotoxic reactivity 
was inhibited by competition with unlabeled type-C virus expressing target cells (6, 
8, 33), however, not all type-C virus-infected cells tested gave positive results in the 
inhibition assay and virus-free cell lines were also inhibitory (33). These latter studies 
involved mice aged 40 wk or younger and virus-infected, allogeneic target cells. Mice 
of this age in our studies did not exhibit a  virus-specific cellular immunity but the 
younger mice did react with noninfected allogeneic target  cells;  thus,  it is felt that 
allogeneic reactivity cannot be excluded in these previous studies (6, 8). Of interest in 
the present report was the finding that mice in the older age group, unlike the young 
group, failed to react with virus-negative allogeneic target cells. 
A preliminary characterization of the effector lymphocytes mediating the cytotoxic 
reactivity  is  described  above.  Carbonyl  iron  treatment  with  magnetic  separation 
revealed  that  the  activity  was  not  due  to,  nor  dependent  on,  macrophages.  The 
effector cells failed to adhere to nylon columns nor were they removed by EA or EAC 
monolayers and thus had no surface receptors for immunoglobulins or complement. 
This activity was not changed by anti-0 serum and complement revealing that they 
were  devoid  of  the  theta  antigen  surface  marker.  With  respect  to  all  of these 
characteristics, the effector cells were similar  to previously described N  cells  (7,  9). 
The  effector cells  were  clearly  different  from  the  cells  that  mediated  anti-MSV 
cytotoxicity because the latter  activity was  clearly abrogated  by anti-0 serum  and 
complement. Also, being devoid of receptors for immunoglobulins, they were distin- 
guishable from cells mediating antibody dependent cellular cytotoxicity (34-37). 
The finding of viral specific cell-mediated and humoral immunity cooccurring in 
the same individual animal led to the question of their respective roles and interactions 
in the in vivo immunity of the host. Sera from normal aging mice exhibiting antiviral 
activity  as  measured  by cytotoxicity assays  as  well  as  immune  sera  with  defined 
antiviral  activity were shown  to block the lymphocyte mediated  cytotoxicity. The 
viral specific nature of the blocking activity was further demonstrated by absorption 
experiments with purified viral antigens.  Blocking of cellular cytotoxic activity with 
antisera  to target  cells is  a  well established  phenomenon  (38-41).  Previous studies 
have generally involved analysis of immune lymphocytes and immune sera from mice 
immunized by tumor allografts. The nature of the antigens of the target cells reactive 368  LYMPHOCYTE-MEDIATED  IMMUNITY TO  TYPE-C  VIRUS  IN  THE  MOUSE 
with the isoantibody were presumably of the H-2 complex although recent seroepi- 
demiology studies  indicate that  antivirat  activity cannot  be ruled  out.  Blocking of 
natural killer cell activity with antisera to defined target cell antigens has not been 
reported. The findings reported here of viral-specific natural  killer cell activity and 
blocking activity of sera with  defined antiviral  activity provide an  opportunity to 
examine basic immunological effector responses with a well-defined transplantation 
antigen. The importance of antiviral natural killer cell and blocking activity in the 
host's immune defenses to its naturally occurring tumors is at present not known but 
now appears feasible to examine. 
Antisera  to  gp70  and  p12,  two  structural  proteins,  previously  reported  to  be 
immunologically reactive at the cell surface in productively infected cells (5, 41) were 
shown  to be highly reactive in  the blocking tests.  Of interest was  the  finding that 
none of the antisera completely blocked the cell-mediated reactivity, suggesting that 
more than one target antigen was  involved in the  lymphocyte reactivity. Blocking 
assays using combinations of antisera are currently under study. Although the findings 
establish that the cell-mediated activity to virus infected cells involves recognition of 
gp70 and p12, lymphocyte reactivity with the other viral proteins could not be ruled 
out as the other viral proteins are probably not immunologically reactive on the cell 
surface of the particular cells used.  It is of interest to try to determine whether the 
effective immunogen for this cell-mediated reactivity is the endogenous virus itself or 
cells infected with the endogenous virus. There is some related data suggesting that 
the latter may be the case. For example, after low dose or hyperimmunization of the 
mouse with  virus  (inactivated  but  retaining  high-titered  antigenic  reactivities), no 
cell-mediated  cytotoxicity has  been  observed  (43),  suggesting  that  a  cell-mediated 
immune response is not evoked by type-C viruses in the mouse. The data reporting 
cell-mediated immunity to type-C viruses all involve live replicating virus and thus 
possibly  involve infected cells  rather  than  virions  as  the  immunogen  (19,  44,  45). 
Further, the mouse has been shown to be tolerant to the structural components of the 
virus that  are  produced by the gag gene  (1),  probably a  result of early embryonic 
expression. Thus, the reactivity to p12 may be induced more readily by p12 active at 
the cell surface than the p12 contained in virions. This possibility is supported by the 
fact that recent studies have indicated the expression of a glycosylated gag gene-coded 
precursor polyprotein on the surface of leukemia cells in an immunologically-altered 
form (46, 47). The importance of clarifying these mechanisms for the induced response 
is clear when one notes that  virtually all of the naturally occurring tumors of two 
strains of mice contain this viral structural protein (4). 
Summary 
The natural immune response in mice to their endogenous type-C viruses involves 
a complex interaction between cellular and humoral immune mechanisms. The virus- 
specific immune  reactivities are  a  function of age  and  appear only subsequent  to 
endogenous  virus  expression.  Cellular  immune  activity  was  found  to  reside  in  a 
population of lymphocytes that  were characterized as natural  killer cells based on 
their absence of theta surface antigens or immunoglobulin or complement receptors. 
Cellular and humoral virus-specific immune responses co-occur in the same animal 
and pretreatment of virus-positive target cells with sera from virus-positive aging mice 
is capable of partially blocking the cytotoxic activity of reactive lymphocytes. The KENDE  ET AL.  369 
blocking  activity  of sera  from  individual  mice  increases  as  a  function  of age  and 
endogenous virus expression  and is highly correlated with the virus-specific comple- 
ment-dependent  cytotoxic  activity  of  these  sera.  Mouse  sera,  whether  naturally 
immune  or  immune  as  a  result  of hyperimmunization  with  type-C  virus,  exhibit 
blocking activity  that  can  be  removed by absorption  with  purified  type-C  virus or 
purified  viral glycoprotein  (gp70)  but not by absorption with noninfected syngeneic 
cells.  High-titered and highly specific antisera directed against certain individual  R- 
MuLV structural proteins reveal blocking activity. Monospecific antisera to gp70 and 
p 12 exhibited high-titered blocking reactivities which are absorbable by the respective 
purified proteins.  Blocking activity of antisera directed against other viral structural 
proteins could not be excluded with certainty. These findings raise the possibility that 
immunity  in  the  mouse  to endogenous  type-C  virus or virus-infected  cells  involves 
competition  between  serum-blocking  activity  and  natural-killer  cell  activity  and 
further  provides  a  unique  model  system  for studying  the  mechanism  of action  of 
blocking antisera known to have monospecific reactivity against defined and purifiable 
transplantation  antigens. 
Received  for publication 17July 1978. 
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